Soligenix
SNGX
#10980
Rank
NZ$13.6 M
Marketcap
NZ$0.63
Share price
-0.03%
Change (1 day)
-86.38%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -NZ$20.01 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$20.58 Million a decrease over its 2024 earnings that were of -NZ$16.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$20.01 Million-2.77%
2025 -NZ$20.58 Million26.72%
2024 -NZ$16.24 Million22.96%
2023 -NZ$13.21 Million-45.74%
2022 -NZ$24.33 Million11.88%
2021 -NZ$21.75 Million-32.37%
2020 -NZ$32.16 Million83.18%
2019 -NZ$17.56 Million11.57%
2018 -NZ$15.74 Million19.29%
2017 -NZ$13.19 Million33%
2016 -NZ$9.92 Million-19.7%
2015 -NZ$12.35 Million5.16%
2014 -NZ$11.75 Million
2010 -NZ$13.26 Million26.12%
2009 -NZ$10.51 Million75.1%
2008 -NZ$6.01 Million-45.38%
2007 -NZ$10.99 Million-22.84%
2006 -NZ$14.24 Million66.15%
2005 -NZ$8.58 Million-16.65%
2004 -NZ$10.29 Million13.28%
2003 -NZ$9.08 Million-11.88%
2002 -NZ$10.31 Million-59.44%
2001 -NZ$25.4 Million378.18%
2000 -NZ$5.32 Million-38.53%
1999 -NZ$8.65 Million-18.43%
1998 -NZ$10.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.11 B-222,070.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.39 B-90,591.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.29 B-65,535.84%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-NZ$31.53 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$72.53 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.94 B-19,503.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-NZ$4.79 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.10 B-604.96%๐Ÿ‡บ๐Ÿ‡ธ USA